HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy

Get up to date on the new antimicrobial agents in the management of HABP and VABP including MDR gram-negative infections at this live symposium with case discussions and a faculty question and answer session. Reinforce your learning with an on-demand video downloadable slides a podcast and companion expert-authored commentaries.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.